Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Better Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

	Security   Type	Security Class   Title	Fee   Calculation   or Carry   Forward   Rule	Amount   Registered(1)	Proposed   Maximum   Offering   Price Per   Unit	Maximum   Aggregate   Offering Price	Fee Rate	Amount of   Registration   Fee
Newly Registered Securities
Fees   Previously   Paid	Equity	Common   Stock, par   value   $0.0001 per   share	457(c)	20,000,000(2)	$0.2112(3)	$4,224,000	0.0001476	$623.47
Carry Forward Securities
Carry   Forward   Securities
	Total Offering Amounts					$4,224,000		$623.47
	Total Fees Previously Paid							$623.47
	Total Fee Offsets							—
	Net Fee Due							0

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional shares of common stock, par value $0.0001 per share (“Common Stock”), of Better Therapeutics, Inc. (the “Company”) as may be issued or issuable because of stock splits, stock dividends, stock distributions, and similar transactions.

(2) Includes 20,000,000 shares of Common Stock that are available to be issued and sold by the Company to Chardan Capital Markets LLC (“Chardan”) from time to time at the Company’s election pursuant to a ChEF Purchase Agreement, dated as of December 13, 2023, between the Company and Chardan, subject to satisfaction of the conditions set forth therein.

(3) Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Common Stock on The Capital Market on December 12, 2023. This calculation is in accordance with Rule 457(c) of the Securities Act.